Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Review the latest news and information on the COVID-19 Pandemic.
read more
BioIVT announced the opening of its new blood donor center on the Tufts University campus in Medford, MA to support academic and pharmaceutical researchers involved in COVID-19, cell and gene therapy research.
read more
Beroni Group has been added to the list of Commercial Manufacturers and Laboratories which have notified the FDA they have validated serology tests.
read more
Horizon Discovery Group announced the addition of an arrayed CRISPR knockout screening service for primary human B cells to its cell-based screening services.
read more
OptimizeRx has launched TelaRep™, its latest EHR-enabled digital health tool designed to support physicians who are treating patients with specialty drug therapies.
read more
Cytovance® Biologics has announced the appointment of Dr. Jesse McCool to Chief Executive Officer.
read more
Emergent BioSolutions has entered into a formal partnership with the U.S. government to expedite development of a plasma-derived therapy for patients with COVID-19.
read more
The PBOA reports that many of its member companies are actively involved in helping their clients develop and produce treatments, vaccines, and diagnostics for COVID-19. PBOA’s members provide a wide array of services throughout the bio/pharma sector...
read more
Wednesday, April 08, 2020
The U.S. Food and Drug Administration (FDA) has released the following statement regarding the current compounding policy.
read more
Wednesday, April 08, 2020
Lannett is set to meet with the FDA on June 9, 2020 to plan next steps for the clinical advancement of its biosimilar insulin glargine partnered product candidate.
read more
Wednesday, April 08, 2020
FFF Enterprises announced its decision to expand its supply of essential medications to support and equip healthcare providers in their battle against COVID-19.
read more
Wednesday, April 08, 2020
The FDA approved the first generic of Proventil HFA Metered Dose Inhaler, 90 mcg/Inhalation, for treatment or prevention of bronchospasm.
read more
Wednesday, April 08, 2020
Lodo has achieved a preclinical milestone in its multi-target strategic collaboration with Genentech, a member of the Roche Group.
read more
Wednesday, April 08, 2020
Cambrex has completed an expansion of its biopharmaceutical analysis capabilities at the Durham, North Carolina site.
read more
CROMSOURCE has announced that it has initiated its first COVID-19 trial on behalf of a European pharmaceutical company.
read more